Flow Cytometry in Lung Disease Prognosis
Author Information
Author(s): Novoa-Bolivar Erika M., Ros José A., Pérez-Fernández Sonia, Campillo José A., López-Hernández Ruth, González-López Rosana, Otálora-Alcaraz Almudena, Ortuño-Hernández Cristina, Gimeno Lourdes, Ruiz-Lorente Inmaculada, Ceballos-Francisco Diana, Muro Manuel, Solana Elena, Martinez-Camblor Pablo, Minguela Alfredo, Wilson Mark R.
Primary Institution: Clinical University Hospital Virgen de la Arrixaca (HCUVA), Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), Spain
Hypothesis
The prognostic value of bronchoalveolar lavage (BAL) cell counts in interstitial lung diseases (ILDs) is unknown.
Conclusion
Flow cytometry quantification of lymphocytes and neutrophils in BAL can effectively stratify risk and predict overall survival in patients with ILDs.
Supporting Evidence
- Patients with lymphocytes > 7% had a longer overall survival compared to those with lower counts.
- Neutrophils < 5% were associated with better survival outcomes.
- A scoring model combining lymphocyte and neutrophil counts with patient age was proposed for predicting survival.
Takeaway
Doctors can use a special test to count certain cells in the lungs to help figure out how sick someone is and how long they might live.
Methodology
This retrospective study analyzed BAL samples from patients with ILD using flow cytometry to quantify lymphocytes and neutrophils.
Potential Biases
Potential biases may arise from the exclusion of patients with certain conditions and the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all variables affecting patient outcomes.
Participant Demographics
The study included 1074 patients with ILD, with a mean age of 58.7 years and a majority being male.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website